HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
25 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
CTSS
cathepsin S
Chromosome 1 · 1q21.3
NCBI Gene: 1520Ensembl: ENSG00000163131.13HGNC: HGNC:2545UniProt: P25774
195PubMed Papers
20Diseases
1Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Protease
RESEARCH IMPACT
Trending
CLINICAL
Clinical Trials
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
fibronectin bindingcysteine-type endopeptidase activityresponse to acidic pHprotein processingbasal cell carcinomasquamous cell carcinomaskin cancercutaneous melanoma
✦AI Summary

Cathepsin S (CTSS) is a lysosomal cysteine protease with dual roles in immune function and extracellular matrix remodeling 1. As a thiol protease, CTSS mediates antigen processing by cleaving the invariant chain from MHC class II molecules, facilitating antigen presentation 1. Beyond immune regulation, CTSS functions as a secreted protease in extracellular environments. Macrophage-derived CTSS promotes liver fibrogenesis by cleaving collagen 18A1 to release endostatin, which activates hepatic stellate cells via integrin signaling 2. Piezo1-regulated CTSS secretion in macrophages drives inflammatory responses contributing to hepatic fibrosis progression 3. In peripheral nerve regeneration, M2 macrophage-derived CTSS cleaves Ephrin-B2 in fibroblasts to activate Schwann cell repair programs 4. Pathologically, neuronal CTSS elevation promotes neuroinflammation and cognitive decline in aging and Alzheimer's disease through CX3CL1-CX3CR1 and JAK2-STAT3 pathways 5. In cardiovascular disease, stress-induced CTSS elevation increases thrombosis risk via inflammation and oxidative stress mechanisms 6. Recent evidence identifies CTSS as a ferroptosis regulator in hepatocellular carcinoma, where it protects cancer cells by degrading KEAP1 and activating NRF2 antioxidant pathways 7. CTSS inhibition shows therapeutic promise across fibrotic, neurodegenerative, cardiovascular, and malignant diseases.

Sources cited
1
CTSS is a lysosomal cysteine protease with distinctive properties including broad pH range activity and roles in antigen processing/presentation
PMID: 35868042
2
Macrophage-derived CTSS cleaves collagen 18A1 to release endostatin, which activates hepatic stellate cells and promotes liver fibrosis
PMID: 37263311
3
Piezo1 activation in macrophages regulates CTSS transcription and secretion, driving inflammatory responses in liver fibrosis
PMID: 37908726
4
M2 macrophage-derived CTSS cleaves Ephrin-B2 in fibroblasts to activate Schwann cells and promote peripheral nerve regeneration
PMID: 37946211
5
Neuronal CTSS promotes neuroinflammation and cognitive decline in aging and Alzheimer's disease via CX3CL1-CX3CR1 and JAK2-STAT3 pathways
PMID: 39453382
6
CTSS elevation increases stress-related thrombosis risk through vascular inflammation, oxidative stress, and endothelial apoptosis
PMID: 37128920
7
CTSS regulates ferroptosis resistance in hepatocellular carcinoma by degrading KEAP1 and activating NRF2 antioxidant responses
PMID: 40784043
Disease Associationsⓘ20
basal cell carcinomaOpen Targets
0.53Moderate
squamous cell carcinomaOpen Targets
0.46Moderate
skin cancerOpen Targets
0.45Moderate
cutaneous melanomaOpen Targets
0.41Moderate
skin neoplasmOpen Targets
0.36Weak
melanomaOpen Targets
0.33Weak
neurodegenerative diseaseOpen Targets
0.30Weak
Nasal Cavity PolypOpen Targets
0.30Weak
atrial fibrillationOpen Targets
0.29Weak
coronary artery diseaseOpen Targets
0.29Weak
actinic keratosisOpen Targets
0.23Weak
neuroinflammatory disorderOpen Targets
0.23Weak
atopic eczemaOpen Targets
0.23Weak
metabolic syndromeOpen Targets
0.21Weak
atrial flutterOpen Targets
0.21Weak
cutaneous squamous cell carcinomaOpen Targets
0.20Weak
cancerOpen Targets
0.16Weak
non-melanoma skin carcinomaOpen Targets
0.16Weak
upper respiratory tract disorderOpen Targets
0.16Weak
prostate carcinomaOpen Targets
0.13Weak
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Drug Targets1
PETESICATIBPhase II
Cathepsin S inhibitor
autoimmune disease
Related Genes
HLA-DRAProtein interaction100%MMP9Protein interaction100%MMP3Protein interaction100%ELANEProtein interaction100%IL10RBProtein interaction100%LAMP1Protein interaction100%
Tissue Expression6 tissues
Bone Marrow
100%
Lung
68%
Liver
13%
Heart
10%
Brain
7%
Ovary
2%
Gene Interaction Network
Click a node to explore
CTSSHLA-DRAMMP9MMP3ELANEIL10RBLAMP1
PROTEIN STRUCTURE
Preparing viewer…
PDB9GJ2 · 1.15 Å · X-ray
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
0.66LoF Tolerant
pLIⓘ
0.19Tolerant
Observed/Expected LoF0.42 [0.28–0.66]
RankingsWhere CTSS stands among ~20K protein-coding genes
  • #2,171of 20,598
    Most Researched195 · top quartile
  • #4,866of 17,882
    Most Constrained (LOEUF)0.66
Genes detectedCTSS
Sources retrieved25 papers
Response time—
📄 Sources
25▼
1
Piezo1 specific deletion in macrophage protects the progression of liver fibrosis in mice.
PMID: 37908726
Theranostics · 2023
1.00
2
Macrophage-Derived Cathepsin S Remodels the Extracellular Matrix to Promote Liver Fibrogenesis.
PMID: 37263311
Gastroenterology · 2023
0.90
3
Cathepsin S (CTSS) activity in health and disease - A treasure trove of untapped clinical potential.
PMID: 35868042
Mol Aspects Med · 2022
0.80
4
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy.
PMID: 36921034
Sci Transl Med · 2023
0.70
5
Gasdermin C cleavage by Cathepsin S modulates Rab7 vesicles in intestinal epithelial cells to amplify anti-helminth immunity.
PMID: 40701157
Immunity · 2025
0.68